Forward-Looking Statements. This presentation contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to known and unknown risks, uncertainties and other important factors that may cause actual results to be materially different from the statements made herein. All statements other than statements of historical fact included in this presentation are forward-looking statements, including, but not limited to, the Company's financial re ...

Acquisition of Ask Sage - BigBear.ai announced the acquisition of Ask Sage, an advanced generative-AI platform tailored for government agencies and highly regulated industries[11, 13] - Ask Sage's ARR grew 6X from '24-'25 and currently serves 16,000 government teams[13] - Ask Sage offers a secure platform for AI use in USG/DoD, reliable data and system connectivity, a marketplace for AI-powered tools, and services for custom AI apps[26] - Synergies between Ask Sage and BigBear.ai include cross-selling, customer expansion, tech integration, and go-to-market strategies[28] Financial Highlights (Q3 2025) - The company reported a record ending cash and investments balance of $715 million[33, 34] - The company had a net positive cash and investments position of almost $575 million as of the end of Q3[34] - For the three months ended September 30, 2025, net loss was $2521 thousand, compared to a net loss of $15135 thousand for the three months ended September 30, 2024[40] - For the three months ended September 30, 2025, Adjusted EBITDA was $(9401) thousand[40] - Revenues for the three months ended September 30, 2025 were $33143 thousand with a gross margin of 22.4% and an adjusted gross margin of 27.7%[43] Strategic Focus - The company focuses on disruptive AI software for national security, smart & secure travel & trade, and dual-use platform-level AI[18, 19]

- GAAP LOSS PER COMMON SHARE FROM CONTINUING OPERATIONS OF $(0.13) -- DISTRIBUTABLE LOSS PER COMMON SHARE OF $(0.94) -- DISTRIBUTABLE LOSS PER COMMON SHARE BEFORE REALIZED LOSSES OF $(0.04) -       NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Ready Capital Corporation (“Ready Capital” or the “Company”) (NYSE: RC), a multi-strategy real estate finance company that originates, acquires, finances, and services lower-to-middle-market (“LMM”) investor and owner-occupied commercial real estate loans, today reporte ...

Exhibit 99.2 Financial Supplement Third Quarter 2025 Disclaimers This supplement contains certain non-GAAP financial information relating to CareTrust REIT including EBITDA, Normalized EBITDA, FFO, Normalized FFO, FAD, Normalized FAD, and certain related ratios. Explanatory footnotes and a glossary explaining this non-GAAP information are included in this supplement. Reconciliations of these non-GAAP measures are also included in this supplement or on our website. See "Financials and Filings – Quarterly Res ...

Third Quarter 2025 Results November 6, 2025 This presentation includes forward-looking statements, including forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward- looking statements include, but are not limited to, statements concerning Enovis' plans, goals, objectives, outlook, expectations and intentions, and other statements that are not historical or current fact. Forward-looking statements and are based on Enovis' current expectations ...

NASDAQ: HBIO 3Q25 Earnings Presentation John Duke, President & CEO Mark Frost, Interim CFO & Treasurer November 6, 2025 Forward-Looking Statements and Non-GAAP Financial Information Forward-Looking Statements This document contains forward-looking statements within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995. Forward- looking statements may be identified by the use of words such as "may," "will," "expect," "plan," "anticipate," "estimate," "inte ...

Financial Performance - FY25 - Consolidated revenue reached approximately $14.5 billion, a decrease of 1% year-over-year[12] - Adjusted EBITDA remained flat year-over-year at $881 million[12] - Free cash flow was reported at $204 million[12] - The company repurchased approximately 7% of its shares outstanding, amounting to $125 million in capital return[12] Q4 FY25 Highlights - Consolidated sales increased by 4% year-over-year, reaching $3.7 billion[13] - Adjusted EBITDA for Q4 FY25 was $226 million, with a margin of 6.1%[13] - Strong free cash flow generation of $134 million was achieved during the quarter[13] FY26 Outlook - Sales are projected to be approximately $14.4 billion due to lower expected production volumes[88] - Adjusted EBITDA is expected to be around $845 million, influenced by business performance offsetting volume headwinds[88] - Free cash flow is forecasted at approximately $90 million, impacted by timing shifts and increased growth spending[88] Regional Sales Performance (Q4 FY25) - Americas sales outperformed the market by 100 bps due to favorable volume/mix[51] - EMEA sales underperformed the market by 400 bps mainly due to customer mix[51]

Core Insights - Standard BioTools Inc. reported financial results for Q3 2025, highlighting a focus on operational efficiency and cost savings initiatives aimed at achieving profitability by 2026 [3][4][7]. Financial Performance - Q3 2025 revenue from continuing operations was $19.6 million, a decrease of 11% year-over-year from $22.1 million in Q3 2024 [6][12]. - Gross margin for Q3 2025 was 48.5%, down from 54.9% in Q3 2024, while non-GAAP gross margin was 53.5%, compared to 57.3% in the same period last year [6][12]. - Operating expenses increased to $42.4 million in Q3 2025, up 9% from $38.8 million in Q3 2024, largely due to restructuring charges [6][12]. - The net loss from continuing operations for Q3 2025 was $31.7 million, compared to a net loss of $21.9 million in Q3 2024, marking a 45% increase in losses [6][12]. Operational Restructuring - The company implemented a phased operational restructuring plan expected to yield over $40 million in annualized cost savings by 2026, including a 20% reduction in workforce [4][5]. - The restructuring aims to enhance operational efficiency and align resources with long-term strategic goals, contributing to a path toward positive adjusted EBITDA in 2026 [4][5]. Cash Position and Future Outlook - As of September 30, 2025, Standard BioTools had $217 million in cash and cash equivalents, with an anticipated increase to approximately $550 million following a pending transaction with Illumina in the first half of 2026 [7][10]. - The company continues to expect full-year 2025 revenue in the range of $165 million to $175 million, with revenue from continuing operations projected between $78 million and $83 million [10]. Market Position and Strategy - Standard BioTools is positioned to expand its portfolio through strategic mergers and acquisitions, leveraging a strong balance sheet and cash reserves to drive growth and deliver long-term shareholder value [3][7].

Q3 2025 Financial Performance - Net sales decreased by $131 million, a 16% decrease year-over-year, primarily due to lower sales in North America On-Highway, Global Off-Highway, Service Parts, Support Equipment & Other, and Outside North America On-Highway end markets, partially offset by higher sales in the Defense end market and price increases on certain products[17] - Net income decreased by $63 million, a 32% decrease year-over-year, to $137 million, principally driven by lower gross profit and acquisition-related expenses[14, 17] - Adjusted EBITDA decreased by $49 million, a 16% decrease year-over-year, to $256 million, driven by lower gross profit[14, 17] - Adjusted EBITDA margin was 36.9%, a decrease of 10 bps year-over-year, remaining essentially flat despite a challenging operating environment[14, 17] - Adjusted Free Cash Flow decreased by $26 million, a 12.4% decrease year-over-year, to $184 million, driven by lower net cash provided by operating activities and higher capital expenditures[14, 18] Segment Performance - North America On-Highway net sales decreased by 28% to $327 million, principally driven by lower demand for Class 8 vocational and medium duty trucks, partially offset by price increases and market share gains for hybrid propulsion systems for transit buses[16] - Outside North America On-Highway net sales decreased by 3% to $122 million, principally driven by lower demand in Asia, partially offset by higher demand in Europe[16] - Global Off-Highway net sales decreased by 65% to $7 million, principally driven by lower demand from the energy, mining and construction sectors outside of North America[16] - Defense net sales increased by 47% to $78 million, principally driven by increased demand for Tracked vehicle applications, price increases, and the continued execution of growth initiatives[16] - Service Parts, Support Equipment & Other net sales decreased by 5% to $159 million, principally driven by lower demand for aluminum die cast components and support equipment, partially offset by price increases[16]

Financial Performance - Heritage Financial Corporation's net income for Q3 2025 was $192 million[19], with a net interest margin of 364%[19] - The company's ROAE was 852% and ROATCE was 1186% for Q3 2025[19] Adjusted ROATCE was 1216%[19] - The efficiency ratio was 633%, and the adjusted efficiency ratio was 624% for Q3 2025[19] - The company's leverage ratio was 105% and the total capital ratio was 138%[19] Loan Portfolio - Loans receivable totaled $48 billion as of September 30, 2025[19] - Real estate, rental, and leasing comprised 561% of commercial business loans by industry exposure, totaling $2122 million[46] - Nonaccrual loans to loans receivable was 037% in Q3 2025[56] Deposits - Deposits totaled $59 billion as of September 30, 2025[19] - Noninterest demand deposits were 276% of total deposits as of September 30, 2025[22] - The cost of total deposits was 137%[22] Investment Portfolio - The investment portfolio yield was 335%[86] - Investment cashflows are estimated to be $561 million through Q3 of 2028[88] M&A Activity - On September 25, 2025, Heritage Financial Corporation entered into a definitive agreement with Olympic Bancorp, Inc, which has $17 billion in assets[22, 28]